Ladycare Menopause Limited Filleted accounts for Companies House (small and micro)

LADYCARE MENOPAUSE LIMITED - Company Information

false false false false false false false false false true false false false false false false false No description of principal activity 2018-07-01 Sage Accounts Production Advanced 2019 - FRS102_2014 25,000 25,000 25,000 xbrli:pure xbrli:shares iso4217:GBP 04685742 2018-07-01 2019-06-30 04685742 2019-06-30 04685742 2018-06-30 04685742 2017-07-01 2018-06-30 04685742 2018-06-30 04685742 bus:Director1 2018-07-01 2019-06-30 04685742 core:WithinOneYear 2019-06-30 04685742 core:WithinOneYear 2018-06-30 04685742 core:ShareCapital 2019-06-30 04685742 core:ShareCapital 2018-06-30 04685742 core:RetainedEarningsAccumulatedLosses 2019-06-30 04685742 core:RetainedEarningsAccumulatedLosses 2018-06-30 04685742 core:NetGoodwill 2019-06-30 04685742 core:NetGoodwill 2018-06-30 04685742 bus:SmallEntities 2018-07-01 2019-06-30 04685742 bus:AuditExemptWithAccountantsReport 2018-07-01 2019-06-30 04685742 bus:FullAccounts 2018-07-01 2019-06-30 04685742 bus:SmallCompaniesRegimeForAccounts 2018-07-01 2019-06-30 04685742 bus:PrivateLimitedCompanyLtd 2018-07-01 2019-06-30

COMPANY REGISTRATION NUMBER: 04685742

Ladycare Menopause Limited

Filleted Unaudited Financial Statements

30 June 2019

Ladycare Menopause Limited

Statement of Financial Position

30 June 2019

	2019		2018
Note	£	£	£

Fixed assets

Intangible assets	5	25,000	25,000
Tangible assets	6	9,633	9,616
		--------	--------
		34,633	34,616

Current assets

Stocks		29,895	30,500
Debtors	7	201,115	154,597
Cash at bank and in hand		197,936	384,820
		---------	---------
		428,946	569,917

Creditors: amounts falling due within one year	8	193,648		259,811
		---------		---------
Net current assets			235,298	310,106
			---------	---------
Total assets less current liabilities			269,931	344,722
			---------	---------

Capital and reserves

Called up share capital	10,000	10,000
Profit and loss account	259,931	334,722
	---------	---------
Shareholders funds	269,931	344,722
	---------	---------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.

For the year ending 30 June 2019 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;

- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

Ladycare Menopause Limited

Statement of Financial Position (continued)

30 June 2019

These financial statements were approved by the board of directors and authorised for issue on 27 March 2020 , and are signed on behalf of the board by:

Mr D R Price
Director

Company registration number: 04685742

Ladycare Menopause Limited

Notes to the Financial Statements

Year ended 30 June 2019

1. General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 24 Emery Road, Brislington, Bristol, BS4 5PF.

2. Statement of compliance

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Judgements and key sources of estimation uncertainty

The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

Revenue recognition

Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Income tax

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

Foreign currencies

Foreign currency transactions are initially recorded in the functional currency, by applying the spot exchange rate as at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the exchange rate ruling at the reporting date, with any gains or losses being taken to the profit and loss account.

Tangible assets

Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

	Equipment	-	25% reducing balance

Impairment of fixed assets

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.

Stocks

Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.

Financial instruments

A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.

Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.

4. Employee numbers

The average number of persons employed by the company during the year amounted to 6 (2018: 7 ).

5. Intangible assets

	Goodwill
	£
Cost
At 1 July 2018 and 30 June 2019	25,000
	--------
Amortisation
At 1 July 2018 and 30 June 2019	–
	--------
Carrying amount
At 30 June 2019	25,000
	--------
At 30 June 2018	25,000
	--------

6. Tangible assets

	Equipment	Total
	£	£
Cost
At 1 July 2018	46,417	46,417
Additions	3,228	3,228
	--------	--------
At 30 June 2019	49,645	49,645
	--------	--------
Depreciation
At 1 July 2018	36,801	36,801
Charge for the year	3,211	3,211
	--------	--------
At 30 June 2019	40,012	40,012
	--------	--------
Carrying amount
At 30 June 2019	9,633	9,633
	--------	--------
At 30 June 2018	9,616	9,616
	--------	--------

7. Debtors

	2019	2018
	£	£
Trade debtors	44,655	84,281
Other debtors	156,460	70,316
	---------	---------
	201,115	154,597
	---------	---------

8. Creditors: amounts falling due within one year

	2019	2018
	£	£
Trade creditors	458	( 5,378)
Corporation tax	8,204	65,873
Social security and other taxes	10	27,105
Other creditors	184,976	172,211
	---------	---------
	193,648	259,811
	---------	---------

9. Director's advances, credits and guarantees

10. Related party transactions

The company was under the control of Mr D Price throughout the current and previous year. Mr D Price is the managing director and he and his family are the majority shareholders.